Business Description
Chongqing Zhifei Biological Products Co Ltd
NAICS : 325414
ISIN : CNE100000V20
Share Class Description:
SZSE:300122: Class ACompare
Compare
Traded in other countries / regions
300122.China IPO Date
2010-09-28Description
Chongqing Zhifei Biological Products Co Ltd is a biotech company. It is a Chinese firm and engaged in the research and development, production, Distribution and import and export and sale of vaccines.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.59 | |||||
Equity-to-Asset | 0.61 | |||||
Debt-to-Equity | 0.15 | |||||
Debt-to-EBITDA | 0.57 | |||||
Interest Coverage | 113.1 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 4.8 | |||||
Beneish M-Score | -1.91 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 52.9 | |||||
3-Year EBITDA Growth Rate | 34.6 | |||||
3-Year EPS without NRI Growth Rate | 34.7 | |||||
3-Year FCF Growth Rate | 44.6 | |||||
3-Year Book Growth Rate | 57.7 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 34.59 | |||||
9-Day RSI | 30.66 | |||||
14-Day RSI | 29.04 | |||||
6-1 Month Momentum % | -44.72 | |||||
12-1 Month Momentum % | -24.7 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.26 | |||||
Quick Ratio | 1.64 | |||||
Cash Ratio | 0.15 | |||||
Days Inventory | 98.4 | |||||
Days Sales Outstanding | 185.97 | |||||
Days Payable | 124.3 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.8 | |||||
Dividend Payout Ratio | 0.15 | |||||
3-Year Dividend Growth Rate | 15.4 | |||||
5-Year Yield-on-Cost % | 6.89 | |||||
3-Year Average Share Buyback Ratio | 0.9 | |||||
Shareholder Yield % | 0.05 |
Profitability Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 26.02 | |||||
Operating Margin % | 17.93 | |||||
Net Margin % | 14.11 | |||||
FCF Margin % | 8.78 | |||||
ROE % | 25.31 | |||||
ROA % | 15.35 | |||||
ROIC % | 27.22 | |||||
ROC (Joel Greenblatt) % | 31.55 | |||||
ROCE % | 28.96 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 8.88 | |||||
PE Ratio without NRI | 8.15 | |||||
Shiller PE Ratio | 18.74 | |||||
Price-to-Owner-Earnings | 10.29 | |||||
PEG Ratio | 0.18 | |||||
PS Ratio | 1.26 | |||||
PB Ratio | 2.03 | |||||
Price-to-Tangible-Book | 2.12 | |||||
Price-to-Free-Cash-Flow | 14.3 | |||||
Price-to-Operating-Cash-Flow | 11.58 | |||||
EV-to-EBIT | 7.81 | |||||
EV-to-EBITDA | 7.81 | |||||
EV-to-Revenue | 1.29 | |||||
EV-to-FCF | 14.83 | |||||
Price-to-Projected-FCF | 1.11 | |||||
Price-to-DCF (Earnings Based) | 0.26 | |||||
Price-to-DCF (FCF Based) | 0.46 | |||||
Price-to-Median-PS-Value | 0.07 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.33 | |||||
Price-to-Graham-Number | 0.88 | |||||
Price-to-Net-Current-Asset-Value | 2.67 | |||||
Earnings Yield (Greenblatt) % | 12.8 | |||||
FCF Yield % | 7.03 | |||||
Forward Rate of Return (Yacktman) % | 23.91 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Chongqing Zhifei Biological Products Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 53,140.677 | ||
EPS (TTM) (Â¥) | 3.124 | ||
Beta | 1.75 | ||
Volatility % | 57.45 | ||
14-Day RSI | 29.04 | ||
14-Day ATR (Â¥) | 0.895382 | ||
20-Day SMA (Â¥) | 30.1045 | ||
12-1 Month Momentum % | -24.7 | ||
52-Week Range (Â¥) | 27.51 - 70.27 | ||
Shares Outstanding (Mil) | 2,393.79 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Chongqing Zhifei Biological Products Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Chongqing Zhifei Biological Products Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Chongqing Zhifei Biological Products Co Ltd Frequently Asked Questions
What is Chongqing Zhifei Biological Products Co Ltd(SZSE:300122)'s stock price today?
The current price of SZSE:300122 is ¥27.73. The 52 week high of SZSE:300122 is ¥70.27 and 52 week low is ¥27.51.
When is next earnings date of Chongqing Zhifei Biological Products Co Ltd(SZSE:300122)?
The next earnings date of Chongqing Zhifei Biological Products Co Ltd(SZSE:300122) is .
Does Chongqing Zhifei Biological Products Co Ltd(SZSE:300122) pay dividends? If so, how much?
The Dividend Yield %  of Chongqing Zhifei Biological Products Co Ltd(SZSE:300122) is 1.8% (As of Today), Highest Dividend Payout Ratio of Chongqing Zhifei Biological Products Co Ltd(SZSE:300122) was 2.46. The lowest was 0.03. And the median was 0.2. The  Forward Dividend Yield % of Chongqing Zhifei Biological Products Co Ltd(SZSE:300122) is 0%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |